Certain Ordinary Shares of GenSight Biologics S.A. are subject to a Lock-Up Agreement Ending on 15-JAN-2017. These Ordinary Shares will be under lockup for 187 days starting from 12-JUL-2016 to 15-JAN-2017. Details: Each shareholder that is a director or an executive officer of the company has agreed, for a period ending 720 calendar days after the settlement date, subject to certain exceptions, with the underwriters not to, without the prior written consent of the underwriters, offer, sell, pledge, lend, grant or sell any option to purchase or enter into any other agreement or transaction. 100% of these shares will be under lock up for the first 12 months, 66.66% and 33.33% of these shares for subsequent 6 month periods thereafter. Other shareholders have agreed, for a period ending 540 calendar days after the settlement date, subject to certain exceptions, with the underwriters not to, without the prior written consent of the underwriters, offer, sell, pledge, lend, grant or sell any option to purchase or enter into any other agreement or transaction. 100% of these shares will be under lock up for the first 6 months, 66.66% and 33.33% of these shares for subsequent 6 month periods thereafter.